BioAscent’s COO, Sylviane Boucharens named in top 50 Movers and Shakers in BioBusiness. BioAscent Discovery Limited’s COO, Dr Sylviane Boucharens, has been included in the BioBeat 2018 list of 50 Movers and Shakers in BioBusiness. Her nomination follows an incredibly successful year in which she has spearheaded the company’s expansion to become a fully integrated drug discovery CRO. Co-founded by Dr Boucharens in 2013, BioAscent initially focused on compound management....
Absolute Antibody Ltd., specialists in antibody sequencing, engineering and recombinant expression with a vision to make recombinant antibody technology accessible to all, has announced the opening of a new facility in northeast England. The new facility more than doubles Absolute Antibody’s laboratory space and will enable an even greater increase in its antibody production capacity, allowing the company to better service customers and accelerate the expansion of its recombinant antibody portfolio....
DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes. Broad Institute CRISPR-Cas9 technology will be combined with DefiniGEN’s best-in-class induced Pluripotent Stem Cell (iPSC) differentiation platform to generate preclinical cell models which can accelerate....
Platform Patent for Clustering a Subset of Antigens for Diagnosing Diseases. ImmunArray, a molecular diagnostic company co-headquartered in Rehovot, Israel and Richmond, Virginia, whose novel blood tests are pioneering new and more accurate ways to diagnose diseases detected by changes in the immune system, has announced that the U.S. Patent and Trademark Office (USPTO) recently issued a new patent that covers one of ImmunArray’s core diagnostic protocols – generic methods....
Frost & Sullivan has presented INTEGRA Biosciences with the ‘2018 Global Laboratory Pipetting Company of the Year’ award, recognizing its products as innovative, revolutionary and able to fulfil the needs of customers. Frost & Sullivan’s transformational health research group conducted extensive research using key benchmarking criteria across two main areas – visionary impact and performance, and customer impact – to compare companies in the industry, and found that INTEGRA surpassed the competition....
The biocluster located in the Greater Paris region is the first European park to receive the Association of University Research Parks (AURP) award. Genopole, a French biocluster dedicated to research in the fields of genetics and biotechnology, today announces it has received the AURP Award of Excellence for Outstanding Research Park. This is the first time a member outside the US has been acknowledged. The announcement was made during AURP’s International Annual Conference in Baltimore (Maryland)...
Global support for Holotomography Microscopy as company prepares for introduction of second microscope model. A comprehensive network of specialist imaging companies has been unveiled to support the sales and maintenance of Tomocube’s holotomography microscopes around the world. Covering North America, Europe and Asia, the 23-strong group is being launched as Tomocube prepares to introduce its second microscope model in less than three months....
Joint further development of 3D visualizations of multidimensional image data. ZEISS and arivis have now expanded and deepened their cooperation, which began in 2014. The companies are pursuing the common goal of enabling new findings in life sciences and in materials research by improving the presentation and analysis of digital data. Modern microscope systems with high-resolution optics record ever increasing amounts of data, which can only be displayed and analyzed with the help of advanced software...
MediSieve wins 1st runner up at prestigious Boston Biotech Week start up competition. Medical device company, MediSieve, received accolades for their ground breaking work during the Biotech Week held in Boston in September 2018. MediSieve won first runner up for Best Business Plan at the Xcelerate Startup Pitch Competition hosted by Xcelerate Insight and EBD Group. The pitch competition is designed to give early stage companies exposure to possible investors and partners...
A collaboration between Watson-Marlow Fluid Technology Group (WMFTG) and a leading American training institute is helping to deliver first-class learning experiences for the bioprocessing sector. The Golden LEAF Biomanufacturing Training and Education Center (BTEC) in North Carolina, USA is now equipped with WMFTG’s Quantum pump technology: thereby offering users and trainees access to the latest in pump innovation in bioprocessing...
Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments....
LAUDA DR. R. WOBSER GMBH & CO. KG has concluded a comprehensive cooperation agreement with watttron GmbH from Freital. The cooperation between the world market leader for precise temperature control and the start-up company from Freital near Dresden, which is developing an innovative heating system for use in specific industrial processes, includes the exclusive sale of watttron products in North America and the analytical, biotechnology and laboratory technology industries worldwide...
Thermo Fisher and Symphogen to develop new workflows to characterize and monitor the quality of mixed antibody products. Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to deliver validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins.....
Ferring Accesses Evotec's Integrated Small Molecule Discovery and Development Platform to Progress New Molecules from Concept to Potential Drug Candidates. Evotec is Eligible for Undiscovered Research Funding and Milestones. Evotec AG and Ferring Pharmaceuticals ("Ferring") has announced a strategic research alliance to discover and develop new small molecule therapies to treat patients living with fertility and gynaecological conditions...
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that a collaboration for a prospective study in Brazil aiming to validate the Fetal Medicine Foundation’s (FMF’s) algorithm for pre-term preeclampsia. The FMF algorithm, which is based on a European population, will now be applied to a study group representative of the Brazilian population....
The German scientist Johannes Kohl, Ph.D. has won the 2018 Eppendorf & Science Prize for Neurobiology for his work on neural mechanisms underlying parental care. Johannes Kohl carried out his research in the laboratory of Catherine Dulac at Harvard University. His work has revealed how a small population of genetically defined neurons controls the motor, motivational, hormonal, and social aspects of parental behavior in...
A senior researcher at Robert Gordon University (RGU) has been awarded around £1.5million in funding in a single week for public health related research projects, as part of her innovative work with microbes and industrial waste streams. Dr Christine Edwards, from RGU’s School of Pharmacy and Life Sciences, has spent the past year on a sabbatical dedicated to advancing a number of projects in line with her focus on cyanobacterial research....
Collaboration unites a worldwide leader in the clinical diagnostics industry with one of the nation’s top research and healthcare institutions to ideate solutions that will address today’s healthcare challenges. Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, is embarking on an innovation collaboration with Johns Hopkins Medicine to explore co-innovation initiatives with the goal of developing and commercializing novel solutions that address challenges in healthcare....
The Metrohm jubilee year 2018 culminates with a highlight: The three winners of the global competition for the Metrohm Young Chemist Award have been nominated and invited to visit Metrohm International Headquarters in Switzerland. Metrohm has always valued the spirit of innovation and believes in the value of novel research performed by young scientists. Throughout this year, young chemist all over the world had the chance to apply with their research and compete for the Metrohm Young Chemist Award in their home countries...
Funding will be used to improve efficiency of induced pluripotent stem cell production. ROSLINCT, a leading cell and gene therapy contract manufacturing organisation, has announced it is to receive a £1.2 million investment to collaborate with REPROCELL Europe Ltd (REPROCELL), a UK-based stem cell company, on a project which will develop a faster, more cost-effective method of producing clinical-grade induced pluripotent stem cells (iPSCs). The investment comes from Innovate UK’s Medicines Manufacturing Round 2 competition...
Data integrity requires data to be complete, consistent, and accurate throughout their complete lifecycle, providing full transparency and traceability. Industry guidelines such as ALCOA and ALCOA+ describe these requirements, which are used by the FDA, WHO, PIC/S and GAMP. All major Metrohm software products make compliance with the ALCOA and ALCOA+ guidelines easy, for anyone. As regulation becomes stricter, safeguarding the quality of data produced along the manufacturing process and the protection of such data against loss...
Prestigious business award granted in recognition of expert services in cell and gene therapy. Diamond Pharma Services Ltd, a leading technical services and regulatory affairs consulting group, providing expert support and advice to pharmaceutical and biotechnology companies, has received the award for “Best Specialist CRO” at the Oxford Bioscience Network (OBN) Awards, in recognition of the Company’s expert services in cell and gene therapy. The OBN Awards, which are celebrating their 10th anniversary, are one of the UK life science industry’s most...
BioAscent’s COO, Sylviane Boucharens named in top 50 Movers and Shakers in BioBusiness. BioAscent Discovery Limited’s COO, Dr Sylviane Boucharens, has been included in the BioBeat 2018 list of 50 Movers and Shakers in BioBusiness. Her nomination follows an incredibly successful year in which she has spearheaded the company’s expansion to become a fully integrated drug discovery CRO. Co-founded by Dr Boucharens in 2013, BioAscent initially focused on compound management....
Absolute Antibody Ltd., specialists in antibody sequencing, engineering and recombinant expression with a vision to make recombinant antibody technology accessible to all, has announced the opening of a new facility in northeast England. The new facility more than doubles Absolute Antibody’s laboratory space and will enable an even greater increase in its antibody production capacity, allowing the company to better service customers and accelerate the expansion of its recombinant antibody portfolio....
DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes. Broad Institute CRISPR-Cas9 technology will be combined with DefiniGEN’s best-in-class induced Pluripotent Stem Cell (iPSC) differentiation platform to generate preclinical cell models which can accelerate....
Platform Patent for Clustering a Subset of Antigens for Diagnosing Diseases. ImmunArray, a molecular diagnostic company co-headquartered in Rehovot, Israel and Richmond, Virginia, whose novel blood tests are pioneering new and more accurate ways to diagnose diseases detected by changes in the immune system, has announced that the U.S. Patent and Trademark Office (USPTO) recently issued a new patent that covers one of ImmunArray’s core diagnostic protocols – generic methods.....jpg)
Frost & Sullivan has presented INTEGRA Biosciences with the ‘2018 Global Laboratory Pipetting Company of the Year’ award, recognizing its products as innovative, revolutionary and able to fulfil the needs of customers. Frost & Sullivan’s transformational health research group conducted extensive research using key benchmarking criteria across two main areas – visionary impact and performance, and customer impact – to compare companies in the industry, and found that INTEGRA surpassed the competition....
The biocluster located in the Greater Paris region is the first European park to receive the Association of University Research Parks (AURP) award. Genopole, a French biocluster dedicated to research in the fields of genetics and biotechnology, today announces it has received the AURP Award of Excellence for Outstanding Research Park. This is the first time a member outside the US has been acknowledged. The announcement was made during AURP’s International Annual Conference in Baltimore (Maryland)...
Global support for Holotomography Microscopy as company prepares for introduction of second microscope model. A comprehensive network of specialist imaging companies has been unveiled to support the sales and maintenance of Tomocube’s holotomography microscopes around the world. Covering North America, Europe and Asia, the 23-strong group is being launched as Tomocube prepares to introduce its second microscope model in less than three months....
Joint further development of 3D visualizations of multidimensional image data. ZEISS and arivis have now expanded and deepened their cooperation, which began in 2014. The companies are pursuing the common goal of enabling new findings in life sciences and in materials research by improving the presentation and analysis of digital data. Modern microscope systems with high-resolution optics record ever increasing amounts of data, which can only be displayed and analyzed with the help of advanced software...
MediSieve wins 1st runner up at prestigious Boston Biotech Week start up competition. Medical device company, MediSieve, received accolades for their ground breaking work during the Biotech Week held in Boston in September 2018. MediSieve won first runner up for Best Business Plan at the Xcelerate Startup Pitch Competition hosted by Xcelerate Insight and EBD Group. The pitch competition is designed to give early stage companies exposure to possible investors and partners...
A collaboration between Watson-Marlow Fluid Technology Group (WMFTG) and a leading American training institute is helping to deliver first-class learning experiences for the bioprocessing sector. The Golden LEAF Biomanufacturing Training and Education Center (BTEC) in North Carolina, USA is now equipped with WMFTG’s Quantum pump technology: thereby offering users and trainees access to the latest in pump innovation in bioprocessing...
Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments....
LAUDA DR. R. WOBSER GMBH & CO. KG has concluded a comprehensive cooperation agreement with watttron GmbH from Freital. The cooperation between the world market leader for precise temperature control and the start-up company from Freital near Dresden, which is developing an innovative heating system for use in specific industrial processes, includes the exclusive sale of watttron products in North America and the analytical, biotechnology and laboratory technology industries worldwide...
Thermo Fisher and Symphogen to develop new workflows to characterize and monitor the quality of mixed antibody products. Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to deliver validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins.....
Ferring Accesses Evotec's Integrated Small Molecule Discovery and Development Platform to Progress New Molecules from Concept to Potential Drug Candidates. Evotec is Eligible for Undiscovered Research Funding and Milestones. Evotec AG and Ferring Pharmaceuticals ("Ferring") has announced a strategic research alliance to discover and develop new small molecule therapies to treat patients living with fertility and gynaecological conditions...
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that a collaboration for a prospective study in Brazil aiming to validate the Fetal Medicine Foundation’s (FMF’s) algorithm for pre-term preeclampsia. The FMF algorithm, which is based on a European population, will now be applied to a study group representative of the Brazilian population....
The German scientist Johannes Kohl, Ph.D. has won the 2018 Eppendorf & Science Prize for Neurobiology for his work on neural mechanisms underlying parental care. Johannes Kohl carried out his research in the laboratory of Catherine Dulac at Harvard University. His work has revealed how a small population of genetically defined neurons controls the motor, motivational, hormonal, and social aspects of parental behavior in...
A senior researcher at Robert Gordon University (RGU) has been awarded around £1.5million in funding in a single week for public health related research projects, as part of her innovative work with microbes and industrial waste streams. Dr Christine Edwards, from RGU’s School of Pharmacy and Life Sciences, has spent the past year on a sabbatical dedicated to advancing a number of projects in line with her focus on cyanobacterial research....
Collaboration unites a worldwide leader in the clinical diagnostics industry with one of the nation’s top research and healthcare institutions to ideate solutions that will address today’s healthcare challenges. 
The Metrohm jubilee year 2018 culminates with a highlight: The three winners of the global competition for the Metrohm Young Chemist Award have been nominated and invited to visit Metrohm International Headquarters in Switzerland. Metrohm has always valued the spirit of innovation and believes in the value of novel research performed by young scientists. Throughout this year, young chemist all over the world had the chance to apply with their research and compete for the Metrohm Young Chemist Award in their home countries...
Funding will be used to improve efficiency of induced pluripotent stem cell production. ROSLINCT, a leading cell and gene therapy contract manufacturing organisation, has announced it is to receive a £1.2 million investment to collaborate with REPROCELL Europe Ltd (REPROCELL), a UK-based stem cell company, on a project which will develop a faster, more cost-effective method of producing clinical-grade induced pluripotent stem cells (iPSCs). The investment comes from Innovate UK’s Medicines Manufacturing Round 2 competition...
Data integrity requires data to be complete, consistent, and accurate throughout their complete lifecycle, providing full transparency and traceability. Industry guidelines such as ALCOA and ALCOA+ describe these requirements, which are used by the FDA, WHO, PIC/S and GAMP. All major Metrohm software products make compliance with the ALCOA and ALCOA+ guidelines easy, for anyone. As regulation becomes stricter, safeguarding the quality of data produced along the manufacturing process and the protection of such data against loss...
Prestigious business award granted in recognition of expert services in cell and gene therapy. Diamond Pharma Services Ltd, a leading technical services and regulatory affairs consulting group, providing expert support and advice to pharmaceutical and biotechnology companies, has received the award for “Best Specialist CRO” at the Oxford Bioscience Network (OBN) Awards, in recognition of the Company’s expert services in cell and gene therapy. The OBN Awards, which are celebrating their 10th anniversary, are one of the UK life science industry’s most...